In the ESPOIR early-arthritis cohort, Gossec et al. reported only 2.6% anti-CCP seroconversion to positivity over two years among initially negative patients, and 4.6% IgM-RF seroconversion [48]. This evidence concerns the gene CD40LG and arthritic joint disease.